Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.43 |
| ▸ | ITK | Q08881 | 1/20 | 0.42 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | CHKA | P35790 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | PDE5A | O76074 | 1/20 | 0.40 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29619639 | 1.00 | NPSR1 (0.45) | NPSR1HTTL3MBTL1CYP2A6SIGMAR1 | |
| SCHEMBL279628 | 0.94 | CYP1A2 (0.42) | NPSR1HTTL3MBTL1CYP2A6SIGMAR1 | |
| SCHEMBL22764497 | 0.94 | CHKA (0.44) | NPSR1HTTL3MBTL1CYP2A6SIGMAR1 | |
| SCHEMBL12048724 | 0.94 | NR3C2 (0.42) | NPSR1HTTL3MBTL1CYP2A6SIGMAR1 | |
| SCHEMBL5441435 | 0.93 | HTT (0.49) | NPSR1HTTL3MBTL1CYP2A6SIGMAR1 | |
| SCHEMBL14506081 | 0.92 | ESR1 (0.46) | NPSR1HTTL3MBTL1SIGMAR1ITK | |
| SCHEMBL12047804 | 0.92 | L3MBTL1 (0.41) | NPSR1HTTL3MBTL1CYP2A6SIGMAR1 | |
| SCHEMBL279071 | 0.90 | ALDH1A1 (0.42) | NPSR1HTTL3MBTL1CYP2A6SIGMAR1 | |
| SCHEMBL13826719 | 0.90 | ESR1 (0.42) | NPSR1HTTL3MBTL1CYP2A6SIGMAR1 | |
| SCHEMBL12048712 | 0.90 | ESR1 (0.42) | NPSR1HTTL3MBTL1CYP2A6SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0986759-B1 | USE OF A FLUORESCENT PROTEIN FOR DETECTING THE INTERACTION BETWEEN A MEMBRANE RECEPTOR AND ITS LIGAND | CENTRE NAT RECH SCIENT (FR) | 2006-04-26 | — | — | EP | claimed |
| WO-2004013178-A1 | FUSION PROTEINS BETWEEN A FLUORESCENT PROTEIN AND AN IONOTROPIC RECEPTOR AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2004-02-12 | — | — | WO | claimed |
| EP-0986759-A2 | USE OF A FLUORESCENT PROTEIN FOR DETECTING INTERACTION BETWEEN A TARGET PROTEIN AND ITS LIGAND | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2000-03-22 | — | — | EP | claimed |
| WO-1998055873-A2 | USE OF A FLUORESCENT PROTEIN FOR DETECTING INTERACTION BETWEEN A TARGET PROTEIN AND ITS LIGAND | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1998-12-10 | — | — | WO | claimed |
| US-20240067664-A1 | Organic Compound, Light-Emitting Device, Display Device, Electronic Device, Light-Emitting Apparatus, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-02-29 | — | — | US | disclosed |
| US-20240067664-A1 | Organic Compound, Light-Emitting Device, Display Device, Electronic Device, Light-Emitting Apparatus, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-02-29 | — | — | US | disclosed |
| US-20240024266-A1 | Therapeutic Agent or Prophylactic Agent for COVID-19 | HIROSHIMA UNIVERSITY (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20240024266-A1 | Therapeutic Agent or Prophylactic Agent for COVID-19 | HIROSHIMA UNIVERSITY (JP) | 2024-01-25 | — | — | US | disclosed |
| US-11858911-B2 | Squarylium compounds and infrared cut films, infrared cut filters and electronic devices including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-01-02 | — | — | US | disclosed |
| US-11858911-B2 | Squarylium compounds and infrared cut films, infrared cut filters and electronic devices including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-01-02 | — | — | US | disclosed |
| US-20230337531-A1 | NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| EP-4248997-A1 | THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR COVID-19 | Hiroshima University (JP) | 2023-09-27 | — | — | EP | disclosed |
| US-20060194259-A1 | Method for isolating an allosteric effector of a receptor | UNIVERSITE LOUIS PASTEUR DE STRASSOURG (FR) | 2006-08-31 | — | — | US | disclosed |
| EP-0986759-B1 | USE OF A FLUORESCENT PROTEIN FOR DETECTING THE INTERACTION BETWEEN A MEMBRANE RECEPTOR AND ITS LIGAND | CENTRE NAT RECH SCIENT (FR) | 2006-04-26 | — | — | EP | disclosed |
| US-20050059036-A1 | Use of a fluorescent protein for detecting interaction between a target protein and its ligand | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2005-03-17 | — | — | US | disclosed |
| EP-1514112-A2 | METHOD FOR ISOLATING AN ALLOSTERIC EFFECTOR OF A RECEPTOR | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2005-03-16 | — | — | EP | disclosed |
| WO-2004013178-A1 | FUSION PROTEINS BETWEEN A FLUORESCENT PROTEIN AND AN IONOTROPIC RECEPTOR AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2004-02-12 | — | — | WO | disclosed |
| WO-2003107004-A2 | METHOD FOR ISOLATING AN ALLOSTERIC EFFECTOR OF A RECEPTOR | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2003-12-24 | — | — | WO | disclosed |
| US-5599911-A | Fiber-reactive dyes having a central 1,3,5-triazine ring to which are bonded to a monoazo chromophore having another 1,3,5-triazine moiety and a second chromophore | CIBA-GEIGY CORPORATION (US) | 1997-02-04 | — | — | US | disclosed |
| WO-1996024580-A1 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK A/S (DK) | 1996-08-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337531-A1 | NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CRY1, AHR, CRY2 | NPSR1 2645/4885HTT 1078/4885L3MBTL1 707/4885 |
| US-20240067664-A1 | Organic Compound, Light-Emitting Device, Display Device, Electronic Device, Light-Emitting Apparatus, and Lighting Device | CCND1, CCND2, DRD1 | NPSR1 2830/4885HTT 3449/4885L3MBTL1 294/4885 |
| US-11858911-B2 | Squarylium compounds and infrared cut films, infrared cut filters and electronic devices including the same | CUTA, SQLE, HMGCR | NPSR1 4166/4885HTT 3582/4885L3MBTL1 3737/4885 |
| US-20240024266-A1 | Therapeutic Agent or Prophylactic Agent for COVID-19 | PIN1, ACE2, ACE | NPSR1 2659/4885HTT 1580/4885L3MBTL1 1983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.